{"id":230,"date":"2026-08-11T05:05:42","date_gmt":"2026-08-11T05:05:42","guid":{"rendered":"https:\/\/dentaltransitions.com\/articles\/dental-practice-valuation-multiples-2026\/"},"modified":"2026-08-11T05:05:42","modified_gmt":"2026-08-11T05:05:42","slug":"dental-practice-valuation-multiples-2026","status":"publish","type":"post","link":"https:\/\/dentaltransitions.com\/articles\/dental-practice-valuation-multiples-2026\/","title":{"rendered":"How Are Dental Practice Valuation Multiples Calculated?"},"content":{"rendered":"<h2 id=\"key-takeaways\">Key Takeaways for Dental Practice Owners<\/h2>\n<ul>\n<li>Dental practice valuation multiples are usually calculated by applying a multiple to normalized Adjusted EBITDA, which reflects recurring operating profit after removing owner-specific expenses.<\/li>\n<li>Normalization typically follows five steps: start with net income, add back ITDA, reset owner compensation to a market rate, remove personal expenses, and exclude one-time costs.<\/li>\n<li>Multiples in 2026 can range from 5x\u20138x for regional DSO add-ons to 9x\u201311x for PE-backed platforms, while private buyers usually rely on SDE at 4.0x\u20136.5x.<\/li>\n<li>Key value drivers that can expand multiples include practice scale, diversified provider production, strong payer mix, robust hygiene programs, and professional management depth.<\/li>\n<li>McLerran &amp; Associates delivers CPA-led, diligence-grade valuations that help control profitability narratives and support stronger outcomes\u2014<a href=\"https:\/\/dentaltransitions.com\/contact-us\/\" target=\"_blank\">schedule a free, confidential discovery call<\/a> to see what your practice may be worth today.<\/li>\n<\/ul>\n<h2>Normalizing Adjusted EBITDA for a Dental Practice<\/h2>\n<p>Normalization restates a practice&#8217;s financials to show what a new owner could reasonably earn, after removing seller-specific items and one-time events so buyers can compare practices on a consistent basis. Every add-back should be documented with support and a short explanation, because undocumented add-backs are often discounted or rejected by buyer quality-of-earnings (QoE) analysts.<\/p>\n<figure style=\"text-align: center;\"><img src=\"https:\/\/cdn.aigrowthmarketer.co\/1782231605342-03c5ed4725a3.jpeg\" alt=\"At McLerran &amp; Associates, every engagement is built on an ironclad, CPA-led EBITDA analysis and practice valuation.\" style=\"max-height: 500px;\" loading=\"lazy\" decoding=\"async\"><figcaption><em>At McLerran &amp; Associates, every engagement is built on an ironclad, CPA-led EBITDA analysis and practice valuation.<\/em><\/figcaption><\/figure>\n<p>The five standard normalization steps used in many 2026 dental transactions are:<\/p>\n<ol>\n<li><strong>Start with net income from the prior year&#8217;s tax return or P&amp;L.<\/strong> Advisors typically review 3 years of P&amp;L statements and tax returns, because a single year can be misleading and buyers usually want to see trends in growth, stability, or decline.<\/li>\n<li><strong>Add back ITDA.<\/strong> Add interest expense, income taxes (if shown on the P&amp;L), depreciation, and amortization to arrive at raw EBITDA. Some advisors instead start with operating income and add only depreciation and amortization, but the goal is the same: a consistent earnings figure before financing and non-cash charges.<\/li>\n<li><strong>Normalize owner compensation.<\/strong> Replace the owner&#8217;s actual pay with a market-rate replacement-dentist salary. <a href=\"https:\/\/dentalpracticeloanguide.com\/learn\/dental-practice-ebitda-cash-flow\" target=\"_blank\" rel=\"noindex nofollow\">Buyers often standardize earnings by using fair-market dentist compensation, typically 25\u201335% of personally produced collections<\/a>. The difference between what the owner actually took and what a replacement would cost is added back to EBITDA.<\/li>\n<li><strong>Add back personal and discretionary expenses.<\/strong> <a href=\"https:\/\/dentalpracticeloanguide.com\/learn\/dental-practice-ebitda-cash-flow\" target=\"_blank\" rel=\"noindex nofollow\">Common add-backs include personal vehicle expenses, family members on payroll without a business function, personal cell phone and internet, personal travel labeled as continuing education, and excessive entertainment<\/a>. These items usually benefit the owner but would not continue for a typical buyer.<\/li>\n<li><strong>Add back one-time, non-recurring costs.<\/strong> One-time expenses such as legal fees form a recognized add-back category in dental QoE normalization. Each item should be tested against 3 years of history, and recurring \u201cone-time\u201d expenses appearing in multiple years are commonly rejected by QoE analysts.<\/li>\n<\/ol>\n<h3>Worked Example: $3 Million Collections General Practice<\/h3>\n<p>This example shows how normalization can look for a general dental practice with $3 million in annual collections:<\/p>\n<ul>\n<li><strong>Net income (as reported):<\/strong> $420,000<\/li>\n<li><strong>Add back: Interest, depreciation, amortization:<\/strong> +$85,000<\/li>\n<li><strong>Add back: Owner W-2 compensation above market rate<\/strong> \u2014 owner paid $650,000; market-rate replacement at 30% of $1.8M owner production = $540,000; excess add-back = +$110,000<\/li>\n<li><strong>Add back: Personal expenses run through the practice<\/strong> (vehicle, travel, family payroll): +$55,000<\/li>\n<li><strong>Add back: One-time legal fee (single matter, documented):<\/strong> +$30,000<\/li>\n<li><strong>Less: Replacement associate cost<\/strong> to cover any production gap post-close: \u2212$0 (owner production already normalized above)<\/li>\n<li><strong>Adjusted EBITDA:<\/strong> $700,000 (approximately 23% margin on collections)<\/li>\n<\/ul>\n<p>At a <a href=\"https:\/\/www.thesorso.com\/answers\/dental-practice-ebitda-multiple\" target=\"_blank\" rel=\"noindex nofollow\">5x\u20138x<\/a> multiple that many regional DSO add-on buyers apply to $1M\u2013$3M EBITDA practices in 2026, this practice&#8217;s enterprise value would likely fall in a range of roughly $3.5M\u2013$5.6M. That range can usually be defended only when every add-back is documented and can withstand buyer review. A 2x change in the multiple on $1 million of EBITDA creates a $2 million valuation difference, so careful normalization can be one of the main factors in protecting value.<\/p>\n<h2>2026 Dental Practice EBITDA Multiples by Buyer Type<\/h2>\n<p>The table below compares how the same hypothetical practice \u2014 $3 million in collections and $700,000 in Adjusted EBITDA \u2014 can be valued differently based on buyer type and the earnings metric each buyer uses. Private buyers often use SDE, which adds back the owner&#8217;s full compensation. DSO and institutional buyers usually use Adjusted EBITDA, which normalizes compensation to a market rate. Because these metrics start from different earnings bases, the dollar values are best compared in context rather than as a direct multiple-to-multiple match.<\/p>\n<table>\n<thead>\n<tr>\n<th>Buyer Type<\/th>\n<th>Earnings Metric Used<\/th>\n<th>Indicative Multiple Range (2026)<\/th>\n<th>Illustrative Enterprise Value<\/th>\n<\/tr>\n<\/thead>\n<tbody>\n<tr>\n<td>Individual dentist (private buyer)<\/td>\n<td>SDE \u2014 adds back full owner compensation, reflects total owner-operator benefit<\/td>\n<td>4.0x\u20136.5x SDE for solo and two-doctor practices<\/td>\n<td>Often expressed as 60%\u201375% of trailing collections for SBA-financed individual buyers in 2026; on $3M collections \u2248 $1.8M\u2013$2.25M<\/td>\n<\/tr>\n<tr>\n<td>Regional DSO add-on buyer<\/td>\n<td>Adjusted EBITDA \u2014 owner compensation normalized to market rate<\/td>\n<td><a href=\"https:\/\/www.thesorso.com\/answers\/dental-practice-ebitda-multiple\" target=\"_blank\" rel=\"noindex nofollow\">5x\u20138x<\/a> Adjusted EBITDA for $1M\u2013$3M EBITDA practices in 2026<\/td>\n<td>On $700K Adjusted EBITDA \u2248 $3.5M\u2013$5.6M enterprise value<\/td>\n<\/tr>\n<tr>\n<td>PE-backed platform buyer (emerging platform)<\/td>\n<td>Adjusted EBITDA \u2014 same normalization, higher scale premium<\/td>\n<td>9x\u201311x for $3M\u2013$5M EBITDA emerging-platform deals in 2026<\/td>\n<td>Requires $3M+ Adjusted EBITDA to access this tier; illustrative only at that scale<\/td>\n<\/tr>\n<\/tbody>\n<\/table>\n<p>The gap between private-buyer and DSO outcomes on the same practice can be meaningful. A $2M-revenue practice with $400,000 in Adjusted EBITDA can achieve an estimated 30% higher valuation when sold to a DSO buyer instead of a private buyer, according to McLerran data. Knowing which market your practice most closely fits can be one of the main starting points for planning your exit.<\/p>\n<h2>SDE vs. EBITDA for Solo Sales and DSO Transactions<\/h2>\n<p>SDE and Adjusted EBITDA answer different questions, so the buyer type usually determines which metric applies and how the practice will be run after closing.<\/p>\n<p><strong>SDE<\/strong> is commonly used when the buyer is another dentist who will step into the chair and replace the selling owner with their own labor. Because the buyer is purchasing both a job and a business, the full owner compensation is added back, since it belongs to whoever performs the clinical work. SDE multiples are usually lower than EBITDA multiples, because they are applied to a larger earnings base that includes the owner&#8217;s full compensation.<\/p>\n<p><strong>Adjusted EBITDA<\/strong> is more common when the buyer is a DSO or institutional group that must hire a replacement dentist at market rates. The owner&#8217;s compensation is not added back in full, and only the excess above what a market-rate associate would cost is added back. The valuation methodology often shifts from SDE to Adjusted EBITDA between roughly $750,000 and $1.0M of adjusted earnings, and this zone is where methodology can break down for sellers without dental-specific M&amp;A representation.<\/p>\n<p>In practice, the same office can show $400,000 in SDE and $200,000 in Adjusted EBITDA, with the difference representing the value of the owner-dentist&#8217;s labor that a solo buyer keeps and a DSO must pay at market rates. Neither figure is inherently wrong, because they serve different buyer perspectives. Owners in the $1.5M\u2013$3M revenue range can often attract both buyer types, so a side-by-side valuation from an advisor active in both markets can be especially useful.<\/p>\n<p><a href=\"https:\/\/dentaltransitions.com\/contact-us\/\" target=\"_blank\">Schedule a free, confidential discovery call with McLerran &amp; Associates<\/a> to review a side-by-side valuation showing what your practice may be worth in both the private-buyer and DSO markets.<\/p>\n<figure style=\"text-align: center;\"><img src=\"https:\/\/cdn.aigrowthmarketer.co\/1782231776232-426cf610db07.jpeg\" alt=\"A chat at McLerran &amp; Associates: the dental-specific sell-side advisor and advocate for practice owners guides on how, when, and to whom to sell your practice.\" style=\"max-height: 500px;\" loading=\"lazy\" decoding=\"async\"><figcaption><em>A chat at McLerran &amp; Associates: the dental-specific sell-side advisor and advocate for practice owners guides on how, when, and to whom to sell your practice.<\/em><\/figcaption><\/figure>\n<h2>Key Factors That Influence Dental Practice Multiples<\/h2>\n<p>Two practices with similar annual collections can receive very different bids. The table below highlights 5 value drivers that can move a multiple up or down in 2026 transactions, along with the general direction of impact.<\/p>\n<table>\n<thead>\n<tr>\n<th>Value Driver<\/th>\n<th>Multiple-Expanding Profile<\/th>\n<th>Multiple-Compressing Profile<\/th>\n<th>Estimated Multiple Impact<\/th>\n<\/tr>\n<\/thead>\n<tbody>\n<tr>\n<td>Practice scale and EBITDA size<\/td>\n<td>Multi-location group, $1M+ Adjusted EBITDA<\/td>\n<td>Single-location, sub-$500K EBITDA, owner-dependent<\/td>\n<td>Moving from one to three locations can roughly double the EBITDA multiple and triple EBITDA, which can produce approximately 5x higher enterprise value from scale alone<\/td>\n<\/tr>\n<tr>\n<td>Provider concentration (key-person risk)<\/td>\n<td>Production distributed across multiple providers, associate coverage in place<\/td>\n<td>Owner-dentist produces 90%+ of revenue<\/td>\n<td>Owner producing 90%+ can trigger a 10%\u201320% valuation reduction, and one provider driving 35%\u201340%+ of collections can result in a 1x\u20132x EBITDA discount<\/td>\n<\/tr>\n<tr>\n<td>Payer mix<\/td>\n<td>Commercial or fee-for-service above 50% of collections<\/td>\n<td>Medicaid concentration above 40% of revenue<\/td>\n<td>Heavy Medicaid exposure can trigger a 1x\u20132x EBITDA discount in 2026 buyer underwriting<\/td>\n<\/tr>\n<tr>\n<td>Hygiene program strength<\/td>\n<td>Hygiene revenue at 25%\u201333% of total collections, recall rate above 85%<\/td>\n<td>Hygiene below 20% of collections, declining recall metrics<\/td>\n<td>Hygienist production share of 25%\u201333%, patient retention above 85%, and a diversified payer mix can support top-of-range multiples, while the inverse can compress valuations toward the lower end of the range<\/td>\n<\/tr>\n<tr>\n<td>Management depth and operational systems<\/td>\n<td>Non-owner management team with documented SOPs and KPI dashboards<\/td>\n<td>Owner manages all operations, no management layer<\/td>\n<td>A trained, non-owner management team can add an estimated 1x\u20133x to a dental group&#8217;s EBITDA multiple by reducing personal goodwill risk<\/td>\n<\/tr>\n<\/tbody>\n<\/table>\n<p>Beyond these primary value drivers, several operational red flags can suppress multiples even when EBITDA appears strong. Lease terms with fewer than 5 years remaining can create uncertainty about location continuity, and open regulatory citations can signal compliance risk that buyers may need to address or price into their offer. Financial inconsistencies, such as P&amp;Ls that do not reconcile with tax returns, can raise questions about reporting accuracy and often prompt deeper scrutiny. Deferred capital investment in analog practices can narrow the buyer pool and reduce sale price because buyers may need to fund post-close modernization, while practices with current digital workflows often attract broader and more competitive bidding.<\/p>\n<h2>Frequently Asked Questions<\/h2>\n<h3>How many times EBITDA is a dental practice worth in 2026?<\/h3>\n<p>There is no single multiple that fits every practice, because the applicable range can depend on practice size, buyer type, and operational profile. As a general framework in 2026, smaller, owner-dependent single-location practices often attract lower multiples from DSO add-on buyers, while larger multi-location groups and specialty platforms with management depth and diversified provider production can command higher ranges. Specialty practices in high-demand categories can also see a premium over general dentistry. In many cases, a practice&#8217;s multiple is shaped by its specific normalized EBITDA, its value-driver profile, and the competitive tension created by how it is taken to market, which is what a diligence-grade valuation is designed to clarify.<\/p>\n<h3>What is the difference between SDE and Adjusted EBITDA for a dental practice valuation?<\/h3>\n<p>SDE (Seller&#8217;s Discretionary Earnings) adds back the owner&#8217;s full compensation, including salary, benefits, and personal expenses, to show the total economic benefit available to a hands-on owner-operator. Individual dentist buyers often use SDE because they plan to replace the selling owner with their own clinical work. Adjusted EBITDA, in contrast, normalizes the owner&#8217;s compensation to a market-rate replacement-dentist salary and adds back only the excess above that figure. DSO and institutional buyers usually rely on Adjusted EBITDA because they must hire someone to perform the clinical work after the owner exits. SDE typically produces a larger earnings number paired with a lower multiple, while Adjusted EBITDA produces a smaller earnings number paired with a higher multiple. For practices in the $1.5M\u2013$3M revenue range, both metrics can be relevant, and presenting financials under both frameworks can help attract both buyer types and support stronger competitive tension.<\/p>\n<h3>Why do &#8220;free&#8221; dental practice valuations often collapse in due diligence?<\/h3>\n<p>A free valuation is often a rough estimate, a headline number set by a buyer or broker with limited analytical depth. When a sophisticated DSO or its quality-of-earnings team reviews the financials, undocumented or recurring add-backs may be discounted or rejected, and the agreed value can be renegotiated downward. This process, often called &#8220;re-trading,&#8221; is one of the common ways sellers may leave money on the table. A CPA-led, diligence-grade normalization, where every add-back is tied to source documents, tested against 3 years of history, and prepared to withstand buyer scrutiny, can reduce the risk of re-trading because much of the detailed work is completed before the deal goes to market. McLerran &amp; Associates has evaluated more than 10,000 practices and builds its valuations to a standard that many accountants would recognize as best-in-class.<\/p>\n<h3>What closing adjustments reduce the cash a seller actually receives from the headline price?<\/h3>\n<p>The headline enterprise value, which comes from multiplying Adjusted EBITDA by the selected multiple, usually differs from the cash a seller receives at closing. The standard bridge from enterprise value to seller proceeds includes several adjustments. Net debt, which includes outstanding practice loans, capital leases, and other debt-like obligations, less any cash left in the business, is subtracted from enterprise value to arrive at equity value. A working-capital true-up then compares the operating liquidity delivered at closing against an agreed target and adjusts the price up or down. On many DSO deals, a portion of the purchase price is structured as rollover equity (stock in the acquiring organization), earnouts tied to future performance, or escrow holdbacks released over time. These structures can reduce cash received at close relative to the headline figure. Understanding these mechanics before signing a letter of intent can be helpful, and McLerran &amp; Associates models these details for every client.<\/p>\n<h2>Conclusion: Protecting Your Dental Practice Valuation<\/h2>\n<p>Dental practice valuation multiples are usually applied to normalized Adjusted EBITDA, and that figure can be defended only when the normalization work is done carefully, documented thoroughly, and prepared to withstand buyer review. The multiple applied to that figure is not fixed, and it can be influenced by practice scale, provider depth, payer mix, hygiene economics, and management infrastructure. The same practice can receive materially different offers depending on which buyer market it enters and how the opportunity is presented.<\/p>\n<p>For roughly 35 years, McLerran &amp; Associates has guided owners of established dental practices through this process by building CPA-led, diligence-grade valuations that help shape the narrative around profitability, then creating competition among a vetted pool of qualified buyers to support both price and terms. With approximately 2,000 successful practice sales, more than $2 billion in closed transaction volume, and a transaction rate of roughly 85%\u201390% compared with an industry norm closer to 35%\u201340%, the firm&#8217;s process is designed to support outcomes that hold up from signing through closing.<\/p>\n<figure style=\"text-align: center;\"><img src=\"https:\/\/cdn.aigrowthmarketer.co\/1782231581955-2aa75d9d4697.jpeg\" alt=\"McLerran &amp; Associates team: McLerran is the nation's largest dental-specific sell-side M&amp;A advisory and brokerage firms\" style=\"max-height: 500px;\" loading=\"lazy\" decoding=\"async\"><figcaption><em>McLerran &amp; Associates team: McLerran is the nation&#8217;s largest dental-specific sell-side M&amp;A advisory and brokerage firms<\/em><\/figcaption><\/figure>\n<p>Owners who are weighing a doctor-to-doctor sale, a DSO affiliation, or simply want to understand what their practice may be worth before making any decision can start with a conversation.<\/p>\n<p><a href=\"https:\/\/dentaltransitions.com\/contact-us\/\" target=\"_blank\">Schedule a free, confidential discovery call with McLerran &amp; Associates<\/a> \u2014 call (512) 900-7989, email info@dentaltransitions.com, or visit dentaltransitions.com\/contact-us. The call is confidential, there is no obligation, and if you are not ready to sell today, McLerran can update your valuation for free a year later.<\/p>\n","protected":false},"excerpt":{"rendered":"<p>Learn how dental practice valuation multiples are calculated in 2026. McLerran delivers CPA-led, diligence-grade valuations. Get your estimate today.<\/p>\n","protected":false},"author":1,"featured_media":229,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"inline_featured_image":false,"footnotes":""},"categories":[1],"tags":[],"class_list":["post-230","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-uncategorized"],"_links":{"self":[{"href":"https:\/\/dentaltransitions.com\/articles\/wp-json\/wp\/v2\/posts\/230","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/dentaltransitions.com\/articles\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/dentaltransitions.com\/articles\/wp-json\/wp\/v2\/types\/post"}],"replies":[{"embeddable":true,"href":"https:\/\/dentaltransitions.com\/articles\/wp-json\/wp\/v2\/comments?post=230"}],"version-history":[{"count":0,"href":"https:\/\/dentaltransitions.com\/articles\/wp-json\/wp\/v2\/posts\/230\/revisions"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/dentaltransitions.com\/articles\/wp-json\/wp\/v2\/media\/229"}],"wp:attachment":[{"href":"https:\/\/dentaltransitions.com\/articles\/wp-json\/wp\/v2\/media?parent=230"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/dentaltransitions.com\/articles\/wp-json\/wp\/v2\/categories?post=230"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/dentaltransitions.com\/articles\/wp-json\/wp\/v2\/tags?post=230"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}